{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T23:44:00Z","timestamp":1718235840508},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Electrocardiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jelectrocard.2024.03.008","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:19:08Z","timestamp":1711419548000},"page":"104-108","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Electrocardiographic predictors of response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction"],"prefix":"10.1016","volume":"84","author":[{"given":"Jonathan","family":"Shpigelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciara","family":"Blaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol-Ann","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitriona","family":"Cahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin Mac","family":"Curtain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Bachari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wadeed","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"O'Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2005.09.060","article-title":"Drugs for left ventricular remodeling in heart failure","volume":"96","author":"Frigerio","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0020","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of Sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","article-title":"Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF","volume":"73","author":"Zile","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0035","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/10742484221107799","article-title":"Duration of heart failure with reduced ejection fraction associated with electrocardiographic outcomes before and after sacubitril\/valsartan","volume":"27","author":"Lin","year":"2022","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0045","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/ehf2.13940","article-title":"The benefits of the earlier use of sacubitril\/valsartan in de novo heart failure with reduced ejection fraction patients","volume":"9","author":"Oh","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0050","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jelectrocard.2015.03.015","article-title":"Electrocardiographic right and left bundle branch block patterns in athletes: prevalence, pathology, and clinical significance","volume":"48","author":"Kim","year":"2015","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1573403X10666140514103612","article-title":"The measurement of the QT interval","volume":"10","author":"Postema","year":"2014","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0060","first-page":"353","article-title":"An analysis of the time-relations of","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-8703(47)90421-3","article-title":"The duration of the electrical systole, Q-T, in acute rheumatic carditis in children","volume":"33","author":"Taran","year":"1947","journal-title":"Am Heart J"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10840-020-00765-3","article-title":"Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence","volume":"59","author":"Asensio","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0075","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ejhf.645","article-title":"Global left atrial failure in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0080","first-page":"8","article-title":"Antiarrhythmic effect of Sacubitril-valsartan: cause or consequence of clinical improvement?","author":"Valentim Goncalves","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jelectrocard.2024.03.008_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.642117","article-title":"A simple score to identify super-responders to sacubitril\/valsartan in ambulatory patients with heart failure","volume":"12","author":"Moliner-Abos","year":"2021","journal-title":"Front Physiol"}],"container-title":["Journal of Electrocardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002207362400044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002207362400044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T22:48:19Z","timestamp":1718232499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002207362400044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":17,"alternative-id":["S002207362400044X"],"URL":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2024.03.008","relation":{},"ISSN":["0022-0736"],"issn-type":[{"value":"0022-0736","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrocardiographic predictors of response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Journal of Electrocardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2024.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}